How do you verify an active MDEL before a Canada distributor handoff?
If your Canada launch depends on a planned importer or distributor, do not treat a sales deck or email confirmation as enough. Check the public Medical Device Establishment Licence listing for the exact company, confirm the listed activity fits the real launch model, and keep a separate product-level Medical Devices Active Licence Listing check for any Class II, III, or IV devices in scope. An active MDEL record helps answer whether the establishment appears licensed to import or distribute. It does not prove that your specific device is approved, listed under that MDEL, or ready for sale. This page helps you build the handoff note before paid review time starts.
Target query: how to verify active MDEL Canada.
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL or MDEL eligibility, licence outcome, compliance, safety, effectiveness, distributor suitability, or legal obligations. We organize source-backed evidence for qualified RA/QA professionals or consultants to review.
Pre-production brief
Role
International manufacturer, founder, or first RA/QA hire onboarding a Canadian importer or distributor
Scenario
The team is close to a Canada launch handoff and needs to confirm whether the planned importer or distributor actually holds an active Medical Device Establishment Licence before paid review time starts.
Concrete problem
They do not know how to verify current MDEL status, what the listing proves, what it does not prove, and when they also need a separate Medical Devices Active Licence Listing check for the product itself.
Available inputs
Planned Canadian partner name, any stated MDEL number or company ID, the partner's claimed role in Canada, the device class mix in scope, and any Class II, III, or IV product names that still need separate MDALL checks.
Useful output
- -A dated screenshot or note showing whether the planned importer or distributor appears in the active MDEL listing.
- -A short table of licence number, company name, activities, device-class scope, and annual review timing risk.
- -A separate follow-up list for product-level MDALL checks when Class II, III, or IV devices are involved.
TrueMedDevice role
- -Check and organize the public MDEL record and supporting Health Canada guidance in one place.
- -Separate establishment-status evidence from product-level licence verification so the handoff question stays clean.
- -Leave MDEL need, exemption analysis, and final launch obligations with qualified RA/QA professionals or consultants.
Workflow: verify the establishment record before the consultant call
1. Confirm why you think an MDEL matters in this launch model
Health Canada's public guidance separates product licensing from establishment licensing. Start by writing the partner's real activity in Canada: importing, distributing, or Class I manufacturing for distribution. That prevents the handoff from collapsing into the vague question "do they have the right licence?"
2. Gather exact identifiers before you search
The MDEL listing supports search by licence number, company ID, or combinations of company name, activity, country, and province or state. Get the exact legal name and any MDEL number first so you do not confuse one Canadian entity with another.
3. Read the active record for the facts it actually publishes
A useful handoff note records the licence number, company ID, company name, address, authorized activities, associated device classes, and the senior official shown in the public listing. That gives the consultant or RA/QA lead a dated baseline to compare against the proposed commercial model.
4. Separate establishment status from product-level status
This is the main decision trap. Health Canada says it does not maintain a list of products under an MDEL, and the MDEL does not constitute approval of any specific medical devices imported or distributed by the holder. If the launch includes Class II, III, or IV devices, keep a separate MDALL step for the product-level licence check.
5. Check the annual-review risk if the launch timing is near April
Health Canada's guidance and FAQ say active holders must file an Annual Licence Review before April 1 each year. The 2025 bulletin says Health Canada will cancel the licence if it does not receive the application before April 1, and the holder must immediately stop importing or selling medical devices after cancellation. If a launch relies on that partner, this timing belongs in the handoff.
6. Escalate exceptions and mixed models instead of guessing
GUI-0016 contains activity-based exceptions and scenario examples. If the partner is a retailer, health care facility, temporary loan provider, or another special case, the next useful output is not a confident internal answer. It is a clean question packet for qualified review with the cited scenario, the public record, and the business fact pattern side by side.
What the MDEL record answers and what it does not
| Question | Public source answer | Handoff meaning |
|---|---|---|
| Does the company appear as an active establishment? | The public MDEL listing shows only active MDELs. | Useful starting proof for the establishment record today. |
| Which activity does the listing show? | The record can show authorized activities and associated device classes. | Compare the listing to the real launch role instead of treating any MDEL as interchangeable. |
| Does the record prove a specific product is approved or covered? | No. Health Canada says it does not maintain product lists under an MDEL and that the MDEL does not constitute approval of any specific device. | Run a separate MDALL or product-licence check where needed. |
| Is there a calendar risk on the establishment record? | Yes. Active holders must file Annual Licence Review before April 1 each year or Health Canada can cancel the licence. | If launch timing is close to April, treat the record as time-sensitive and confirm the holder's annual review plan. |
The table above stays inside the public-source boundary. It helps you ask the right next question. It does not resolve the final licensing or commercial-responsibility decision.
Source ledger
Every hard claim in this article maps to an official Health Canada or Health Canada-hosted public URL below.
| Claim supported | Official URL |
|---|---|
| Health Canada says Canada has two medical device licence types: MDL and MDEL, and that MDELs are issued to companies that import Class I to IV devices, distribute Class I to IV devices, or manufacture Class I devices. | https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/about-medical-devices.html |
| GUI-0016 says the guidance covers who requires an MDEL, how to apply, and how to submit the annual licence review before April 1 of each year. | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/guidance-medical-device-establishment-licensing-0016.html |
| GUI-0016 says MDEL holders are responsible for confirming that medical devices are licensed at the time of import or sale, links separately to the active MDEL holder list and the current MDL holder list, and says in general any person who imports into or sells a medical device for human use in Canada requires an MDEL unless an exception applies. | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/guidance-medical-device-establishment-licensing-0016.html |
| The public MDEL listing says it contains company ID, licence number, company name, address, authorized activities, associated device classes, and the senior official name. | https://health-products.canada.ca/mdel-leim/start-debuter.do?lang=en&wbdisable=true |
| The same listing says Health Canada does not maintain a list of products under an MDEL, an MDEL does not constitute approval of any specific medical devices imported or distributed by the holder, and only active MDELs appear in the listing. | https://health-products.canada.ca/mdel-leim/start-debuter.do?lang=en&wbdisable=true |
| The same listing says an establishment remains active unless Health Canada suspends or cancels the MDEL for non-compliance or the company asks for cancellation because it has ceased licensable activities. | https://health-products.canada.ca/mdel-leim/start-debuter.do?lang=en&wbdisable=true |
| Health Canada's FRM-0292 instructions say that if you sell or import any class of medical devices in Canada, you must apply for and maintain an MDEL unless a section 44 exemption applies, and that the senior official's name is published in the MDEL listing. | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/forms/medical-device-establishment-licence-application-form-instructions-0292.html |
| Health Canada's MDEL FAQ says all active MDEL holders must submit an Annual Licence Review before April 1 each year, must pay the fee even if nothing changed, and that failure to submit before April 1 leads to cancellation. | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/annual-review-documents/frequently-asked-questions-medical-device-establishment-licensing-fees.html |
| Health Canada's 2025 annual review bulletin says if Health Canada does not receive the application before April 1, it will cancel the licence, and a cancelled or withdrawn holder must immediately stop importing or selling medical devices. | https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/medical-devices-compliance-bulletin/what-medical-device-establishment-licence-holders-need-know-about-licence-review-2025.html |
| Health Canada's fee table lists the Medical Device Establishment Licence fee as C$5,519 as of April 1, 2026. | https://www.canada.ca/en/health-canada/services/drugs-health-products/funding-fees/fees-respect-human-drugs-medical-devices/medical-device-establishment-licence-funding-fees-drugs-health-products.html/1000?wbdisable=true |
| Health Canada's MDL overview says the system is designed to help verify that the manufacturer has an active medical device licence and that only currently licensed products appear in the Search Active Licence window. | https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/licences/overview.html |
Workload and cost framing
| Layer | What the source says | Operational meaning |
|---|---|---|
| MDEL fee layer | Health Canada lists the Medical Device Establishment Licence fee at C$5,519 as of April 1, 2026. | If a partner must apply for a new MDEL or reinstate one, that should be treated as real launch budget and timing, not background admin. |
| Annual review layer | Active holders must submit Annual Licence Review before April 1 each year and pay the fee even if nothing changed. | An apparently active partner should still be treated as a time-sensitive dependency when the launch calendar sits near the annual review cycle. |
| Verification workload | Inference from the public workflow above, not a direct Health Canada claim. | Expect under an hour if the exact company identifiers are already known, and longer if the business model, entity naming, or product-level MDALL follow-up is still unclear. |
FAQ
If a company appears in the MDEL listing, does that prove our specific device is approved in Canada?
No. Health Canada's MDEL listing says the department does not maintain a list of products under an MDEL and that an MDEL does not constitute approval of any specific medical devices imported or distributed by the holder. For Class II, III, or IV devices, product-level licence verification is a separate MDALL check.
What should I ask a planned Canadian importer or distributor for before the consultant call?
Ask for the exact legal company name, MDEL number if available, the activity they perform in Canada, and the device classes they expect to handle. Those details let you search the public MDEL listing and compare the record to the actual launch plan before paid review time starts.
Can a company lose the right to import or distribute if its annual review is missed?
Yes. Health Canada's annual review bulletin says active MDEL holders must apply before April 1 each year and that if Health Canada does not receive the application before April 1, it will cancel the licence. The bulletin also says a cancelled holder must immediately stop importing or selling medical devices.
Does TrueMedDevice decide whether our business model needs an MDEL, an MDL, or both?
No. TrueMedDevice does not determine device class, MDL or MDEL eligibility, licence outcome, compliance status, safety, effectiveness, or legal obligations. We organize official-source evidence so qualified RA/QA professionals or consultants can review and decide.
Boundary statement
This is not regulatory, legal, or compliance advice. TrueMedDevice does not determine device class, MDL/MDEL eligibility, licence outcome, compliance, safety, or effectiveness. We prepare a source-backed Health Canada / MDALL / public-source evidence pack so qualified RA/QA professionals or regulatory consultants can review and decide.
Need the Canada launch handoff note built around your real partner list?
We can turn public Health Canada establishment and product-licence checks into a dated evidence pack so your first consultant or RA/QA review starts from organized facts instead of scattered screenshots.
Review support only. We do not provide regulatory, legal, or compliance decisions. Final RA/QA, consultant, manufacturer, and partner-selection decisions remain with qualified reviewers.